Skip to main content
FDA panel to vote on safety of Trevena's opioid treatment

The FDA is concerned that Trevena's oliceridine, an opioid injection treatment for acute pain, bears too great a risk for abuse. An FDA panel is scheduled to vote Thursday on the drug's safety.

Full Story: